Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 05, 2020

SELL
$1.51 - $2.27 $53,145 - $79,894
-35,196 Closed
0 $0
Q3 2019

Oct 30, 2019

SELL
$1.59 - $2.51 $15 - $25
-10 Reduced 0.03%
35,196 $73,000
Q2 2019

Jul 19, 2019

BUY
$2.49 - $5.45 $12,948 - $28,340
5,200 Added 17.33%
35,206 $87,000
Q1 2019

May 13, 2019

BUY
$1.47 - $5.91 $1,199 - $4,822
816 Added 2.8%
30,006 $118,000
Q4 2018

Feb 11, 2019

BUY
$1.38 - $2.59 $6,940 - $13,025
5,029 Added 20.81%
29,190 $40,000
Q3 2018

Nov 06, 2018

BUY
$2.2 - $3.45 $53,154 - $83,355
24,161 New
24,161 $60,000

Others Institutions Holding OCX

About Oncocyte Corp


  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $238M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.